Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
The Korean Journal of Internal Medicine|July 1, 1989
Role of blocking TSH receptor antibodies on the development of hypothyroidism and thyroid atrophy in primary myxedemaB Y Cho, Y K Shong, H K Lee, et al.
The Korean Journal of Internal Medicine|January 5, 2002
Clinical significance of classification of Graves' disease according to the characteristics of TSH receptor antibodiesW B Kim, H K Chung, Y J Park, et al.
Journal of Korean Medical Science|October 1, 1993
Negative correlation between the conversion of thyrotropin receptor-bound blocking type thyrotropin receptor antibody to the stimulating type by anti-human IgG antibodies and the biological activity of blocking type thyrotropin receptor antibodyB Y Cho, M H Shong, J H Chung, et al.
Hormone Research|January 11, 2001
Dissociation between plasma adrenocorticotropin and serum cortisol level during the early postoperative period after gastrectomyY M Cho, S Y Kim, B Y Cho, et al.
The Korean Journal of Internal Medicine|July 1, 1989
Pathogenetic role of thyrotropin receptor antibody in the development of hyperthyroidism following primary hypothyroidismY K Shong, B Y Cho, S K Hong, et al.
Journal of Korean Medical Science|March 1, 1990
Thyroglobulin synthesis of oxyphilic cells in various types of neoplastic and autoimmune thyroid diseasesT S Hwang, J S Suh, Y I Kim, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|December 10, 1997
Labeling reactions applicable to chromatography and electrophoresis of minute amounts of proteinsI S Krull, R Strong, Z Sosic, et al.
Allergy|October 3, 2009
Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory diseaseN S Palikhe, S-H Kim, B-Y Cho, et al.
Allergy|February 19, 2009
Combined effect of IL-10 and TGF-beta1 promoter polymorphisms as a risk factor for aspirin-intolerant asthma and rhinosinusitisS-H Kim, E-M Yang, H-N Lee, et al.
Clinical Endocrinology|June 1, 1992
Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' diseaseB Y Cho, M H Shong, K H Yi, et al.
Pageof 7